iShares Neuroscience and Healthcare ETF Rating $39.06 0.00 (0.00%) As of 07/2/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.76Holdings in IBRN have an aggregate rating of Moderate Buy based on 376 analyst ratings issued in the past year covering 23 companies (75.9% of the portfolio).IBRN Aggregate Price Target$39.06High Prediction$39.06Average Prediction$39.06Low Prediction$39.06Holdings in IBRN have an aggregate price target of $39.06 and a range of $39.06 to $39.06 covering 23 companies (75.9% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 IBRN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.46%PRAXPraxis Precision Medicines$318.523.7068 of 5 stars2.95$569.63 78.8%214.26%PTCTPTC Therapeutics$83.313.0807 of 5 stars2.71$91.36 9.7%14Insider TradeGap DownHigh Trading Volume4.19%ARWRArrowhead Pharmaceuticals$83.992.0373 of 5 stars2.69$87.27 3.9%13Analyst ForecastAnalyst RevisionGap Down4.15%SRRKScholar Rock$54.881.7122 of 5 stars3.12$56.00 2.0%17Gap Down4.05%DNTHDianthus Therapeutics$94.342.2814 of 5 stars2.93$117.82 24.9%14Gap Down4.01%ALKSAlkermes$54.581.7591 of 5 stars2.72$49.63 -9.1%18Analyst ForecastInsider TradeGap Down3.96%AXSMAxsome Therapeutics$244.312.2309 of 5 stars2.95$258.95 6.0%21Insider Trade3.95%XENEXenon Pharmaceuticals$60.963.9971 of 5 stars3.00$77.20 26.6%17News CoveragePositive News3.80%BIIBBiogen$216.123.4754 of 5 stars2.52$217.41 0.6%313.78%ARGXargenex$939.683.6692 of 5 stars2.92$1,034.56 10.1%24Analyst Forecast3.77%CNTACentessa Pharmaceuticals$40.501.1286 of 5 stars2.21$41.33 2.1%14Short Interest Decrease3.70%ACADACADIA Pharmaceuticals$25.974.6663 of 5 stars2.65$32.59 25.5%17Analyst Forecast3.68%NBIXNeurocrine Biosciences$174.264.394 of 5 stars2.96$187.52 7.6%23Insider TradeGap Down3.57%DNLIDenali Therapeutics$25.832.5714 of 5 stars2.81$34.25 32.6%163.49%CPRXCatalyst Pharmaceuticals$31.453.4125 of 5 stars2.56$32.00 1.7%9News Coverage2.85%EWTXEdgewise Therapeutics$39.563.3539 of 5 stars2.78$47.30 19.6%9Insider Trade2.75%DYNDyne Therapeutics$23.072.7602 of 5 stars2.86$34.17 48.1%14Insider TradeGap Down2.41%SUPNSupernus Pharmaceuticals$48.052.7343 of 5 stars2.43$62.17 29.4%7News CoverageAnalyst Upgrade2.32%AXGNAxoGen$45.892.0069 of 5 stars2.73$46.50 1.3%11News CoveragePositive NewsAnalyst Upgrade1.94%BHVNBiohaven$15.93-0.2%2.8782 of 5 stars2.67$21.63 35.8%181.78%SRPTSarepta Therapeutics$19.282.948 of 5 stars2.08$24.81 28.7%24Analyst UpgradeGap Down1.54%TSHATaysha Gene Therapies$6.533.1834 of 5 stars3.00$12.62 93.2%14Analyst ForecastGap Up1.53%CAPRCapricor Therapeutics$23.212.1052 of 5 stars2.90$53.67 131.2%10Insider Trade This page (NYSEARCA:IBRN) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRN Stock Alerts